Short-term Outcomes in Patients with Carcinoma of the Esophagus and Gastroesophageal Junction Receiving Neoadjuvant Chemotherapy or Chemoradiation before Surgery. A Prospective Study

BACKGROUND: Neoadjuvant chemotherapy (NACT) and neoadjuvant chemoradiotherapy (NACRT) have been demonstrated to improve survival compared to surgery alone in esophageal carcinoma, but the evidence is scarce on which of these therapies is more beneficial, particularly with regard to resectability rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nusrath, Syed, Thammineedi, Subramanyeshwar Rao, Vijaya Narsimha Raju, K. V., Patnaik, Sujit Chyau, Pawar, Satish, Santa, Ayyagari, Rajappa, Senthil J., Mallavarapu, Krishna Mohan, Raju, Krishnam, Murthy, Sudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363373/
https://www.ncbi.nlm.nih.gov/pubmed/29993360
http://dx.doi.org/10.5041/RMMJ.10339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363373/
https://www.ncbi.nlm.nih.gov/pubmed/29993360
http://dx.doi.org/10.5041/RMMJ.10339

Ejemplares similares